These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33618970)

  • 1. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
    Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016.
    Liu J; Avery RJ; Kim JJ; Niederdeppe J
    J Health Commun; 2022 Mar; 27(3):183-191. PubMed ID: 35593131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
    Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
    Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements.
    Wogalter MS; Shaver EF; Kalsher MJ
    Appl Ergon; 2014 Sep; 45(5):1330-6. PubMed ID: 24377979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising.
    Kiernicki K; Helme DW
    Health Mark Q; 2017; 34(4):284-301. PubMed ID: 29173108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking Repeated Exposure into Account: An Experimental Study of Direct-To-Consumer Prescription Drug Television Ad Effects.
    Betts KR; Aikin KJ; Kelly BJ; Johnson M; Parvanta S; Southwell BG; Mack N; Tzeng J; Cameron L
    J Health Commun; 2019; 24(5):503-511. PubMed ID: 31033396
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
    Eisenberg MD; Singh Y; Sood N
    JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.
    Sullivan HW; Aikin KJ; Poehlman J
    Health Commun; 2019 Feb; 34(2):212-219. PubMed ID: 29125325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.
    Brownfield ED; Bernhardt JM; Phan JL; Williams MV; Parker RM
    J Health Commun; 2004; 9(6):491-7. PubMed ID: 15764448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conflicting prescription drug information from direct-to-consumer advertising and drug injury advertising on patients' beliefs and medication adherence.
    Im H; Huh J
    Res Social Adm Pharm; 2022 Jul; 18(7):3119-3130. PubMed ID: 34454872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising.
    Kelly BJ; Rupert DJ; Aikin KJ; Sullivan HW; Johnson M; Bann CM; Mack N; Southwell BG; West S; Parvanta S; Rabre A; Peinado S
    Res Social Adm Pharm; 2021 May; 17(5):942-955. PubMed ID: 32883618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.